BridgeBio Oncology Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
BridgeBio Oncology Therapeutics, Inc.
CIK #0001869105
EDGAR Form CIK 2011 - 2025
10-K [0001869105]
10-Q [0001869105]
3 [0001869105]
4 [0001869105]
8-K [0001869105]
SC 13D [0001869105]
SC 13G [0001869105]
Form 13D/13G Filer Form 13D/13G Subject Filed
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18]
Flynn James E Bridgebio Oncology Therapeutics Inc [2025-08-18]
Sculptor Capital LP Helix Acquisition Corp II [2025-07-24]
BlackRock Portfolio Management LLC Helix Acquisition Corp II [2025-04-15]
Price T Rowe Associates Inc /MD/ Helix Acquisition Corp II [2024-11-14]
BlackRock Inc Helix Acquisition Corp II [2024-11-08]
BlackRock Inc Helix Acquisition Corp II [2024-10-22]
Citadel Advisors LLC Helix Acquisition Corp II [2024-02-23]
Adage Capital Partners GP LLC Helix Acquisition Corp II [2024-02-23]
Helix Holdings II LLC Helix Acquisition Corp II [2024-02-20]
View All
Form 3/4/5 Subject 2011 - 2025
BridgeBio Oncology Therapeutics, Inc.
Beltran Pedro
Mehra Uneek
Wallace Eli M.
Ben Yong
Kumar Neil
Bauer Jake
BridgeBio Pharma LLC
BridgeBio Pharma, Inc.
McCormick Frank
View All
Terms | Privacy | Guide
tony@aum13f.com